Antiphospholipid antibodies and atherosclerosis

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Danielle Nicolo, Marc Monestier

Abstract

Antiphospholipid antibodies (APA) are present in a variety of autoimmune disorders, including systemic lupus erythematosus (SLE) and the antiphospholipid syndrome (APS). Increasing evidence suggests that a subset of APA can also be detected in patients with atherosclerosis. In this review, we discuss the specificities of the autoantibodies that are present during both APS and atherosclerosis. A critical and unresolved question is whether these APA are specific for epitopes that result from lipid oxidation. Despite the fact that APA are present in patients with systemic autoimmunity and that they may participate in the pathogenesis of APS, recent studies have paradoxically proposed a beneficial role for some APA in atherosclerosis. We review the evidence that some APA specificities may be protective against plaque formation, and we discuss the putative mechanisms by which some APA could be useful in the prevention of atherosclerosis.

References

Jan 1, 1990·British Journal of Haematology·E N Harris
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W PalinskiJ L Witztum
Apr 1, 1987·Arthritis and Rheumatism·G SturfeltK Krook
Dec 1, 1980·The American Journal of Medicine·A K BidaniE J Lewis
Jul 1, 1981·The Journal of Experimental Medicine·L M HangF J Dixon
Jan 1, 1994·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·S Ylä-HerttualaJ L Witztum
Oct 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·W PalinskiJ L Witztum
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·S StemmeG K Hansson
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·W PalinskiJ L Witztum
May 3, 1996·Science·J L Breslow
May 1, 1996·The Journal of Clinical Investigation·K UyemuraR L Modlin
Aug 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·S AmeliJ Nilsson
Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·S HörkköJ L Witztum
Oct 23, 1997·Current Opinion in Lipidology·G K Hansson
Jul 7, 1998·The Journal of Experimental Medicine·F S SutterwalaD M Mosser
Dec 23, 1998·Proceedings of the National Academy of Sciences of the United States of America·G M IversonD M Marquis
Jan 14, 1999·The New England Journal of Medicine·R Ross
Mar 18, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·M F Lopes-VirellaK Y Forrest
Jun 22, 1999·The New England Journal of Medicine·G D Sloop
Aug 14, 1999·Life Sciences·G S HuangS J Mao
Oct 16, 1999·Circulation Research·Z MallatA Tedgui
Aug 18, 2000·Free Radical Biology & Medicine·S HörkköJ L Witztum
Sep 16, 2000·Current Opinion in Rheumatology·R A Roubey
Jan 9, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·X ZhouG K Hansson
Mar 10, 2001·Cell·C K Glass, J L Witztum
Sep 5, 2001·Journal of Clinical Pathology·M HelbertP MacCallum

❮ Previous
Next ❯

Citations

Mar 8, 2013·Current Cardiology Reviews·Nailú Angélica SinicatoSimone Appenzeller
Mar 8, 2008·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Zhongjie MaRobert A Eisenberg
Nov 6, 2007·Seminars in Arthritis and Rheumatism·Cristina C BeliznaHervé Lévesque
Aug 30, 2005·Annals of the New York Academy of Sciences·Sandra ZampieriAndrea Doria
Aug 30, 2005·Annals of the New York Academy of Sciences·Karina de LeeuwMarc Bijl
Jul 9, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Robert A S Roubey
Feb 18, 2006·Autoimmunity Reviews·Luis J JaraMary-Carmen Amigo
Mar 11, 2005·Expert Opinion on Therapeutic Targets·Walid MouradMoncef Zouali
May 3, 2005·Current Opinion in Infectious Diseases·Philip G de Groot, Ronald H M W Derksen
Sep 6, 2005·Arthritis and Rheumatism·Yehuda Shoenfeld, Elias Toubi
Jan 8, 2013·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Yu Funakubo Asanuma
Oct 28, 2019·Arteriosclerosis, Thrombosis, and Vascular Biology·Olga A CherepanovaGary K Owens
Dec 25, 2010·São Paulo Medical Journal = Revista Paulista De Medicina·Mahendra Narain Mishra, Varinder Singh Bedi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.